ArticleCardiovascular revascularization medicine : including molecular interventions2022

Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study.

Nino Mihatov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.